Free Trial

Lonza Group (OTCMKTS:LZAGY) Sees Unusually-High Trading Volume - Still a Buy?

Lonza Group logo with Medical background

Key Points

  • Lonza Group experienced a significant surge in trading volume, with approximately 237,948 shares exchanged, marking a 216% increase compared to the previous session.
  • Analysts at Zacks Research downgraded the stock from a "strong-buy" to a "hold" rating, although the consensus rating remains a "Buy" among two Strong Buy and one Hold ratings from equity analysts.
  • Current financial metrics for Lonza Group include a quick ratio of 1.04, a current ratio of 1.52, and a debt-to-equity ratio of 0.45, indicating a stable financial position.
  • Five stocks to consider instead of Lonza Group.

Lonza Group Ag (OTCMKTS:LZAGY - Get Free Report) saw unusually-strong trading volume on Monday . Approximately 237,948 shares changed hands during trading, an increase of 216% from the previous session's volume of 75,345 shares.The stock last traded at $65.13 and had previously closed at $65.46.

Analysts Set New Price Targets

Separately, Zacks Research cut shares of Lonza Group from a "strong-buy" rating to a "hold" rating in a research note on Monday, September 22nd. Two equities research analysts have rated the stock with a Strong Buy rating and one has given a Hold rating to the company's stock. According to MarketBeat.com, Lonza Group presently has a consensus rating of "Buy".

Read Our Latest Stock Analysis on Lonza Group

Lonza Group Stock Performance

The company has a quick ratio of 1.04, a current ratio of 1.52 and a debt-to-equity ratio of 0.45. The firm's 50 day simple moving average is $69.62 and its 200 day simple moving average is $68.36.

About Lonza Group

(Get Free Report)

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Lonza Group Right Now?

Before you consider Lonza Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lonza Group wasn't on the list.

While Lonza Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.